Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)
China · Delayed Price · Currency is CNY 31.11
-0.15 (-0.48%)
At close: Feb 13, 2026
SHA:688217 Market Cap
SHA:688217 has a market cap or net worth of 1.72 billion as of February 13, 2026. Its market cap has increased by 58.81% in one year.
Market Cap
1.72B
Enterprise Value
1.51B
Revenue
191.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
31.11
Market Cap Chart
Since May 17, 2021, SHA:688217's market cap has decreased from 5.91B to 1.72B, a decrease of -70.97%. That is a compound annual growth rate of -22.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 1.72B | 18.06% |
| Dec 31, 2025 | 1.45B | 42.90% |
| Dec 31, 2024 | 1.02B | -49.08% |
| Dec 29, 2023 | 2.00B | 1.72% |
| Dec 30, 2022 | 1.96B | -51.39% |
| Dec 31, 2021 | 4.04B | -31.67% |
| May 17, 2021 | 5.91B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jilin Jian Yisheng Pharmaceutical | 2.75B |
| Jiangsu CoWin Biotech | 2.71B |
| Jiangsu Sihuan Bioengineering | 2.65B |
| Guiyang Xintian Pharmaceutical | 2.47B |
| Hubei Goto Biopharm | 2.46B |
| Zhejiang East Asia Pharmaceutical | 2.44B |
| Jiangsu Gdk Biological Technology | 2.43B |
| Hunan Nucien Pharmaceutical | 2.31B |